首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Urologie

缩写:UROLOGIE

ISSN:2731-7064

e-ISSN:2731-7072

IF/分区:0.4/Q4

文章目录 更多期刊信息

共收录本刊相关文章索引784
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Markus Angerer,Klaus-Peter Dieckmann,Christian Wülfing Markus Angerer
Background: Retroperitoneal lymph node dissection (RPLND) is an established treatment modality for nonseminomatous germ cell tumours (NSGCT) and selected seminomas. The advent of minimally invasive techniques, particularl...
Axel Heidenreich,David Pfister Axel Heidenreich
Retroperitoneal lymphadenectomy (RPLND) represents an established surgical treatment option for patients with testicular germ cell tumors and might be performed at various clinical stages depending on individual risk factors. Typically, RPL...
Alexander Reinisch-Liese,Juliane Liese,Frank Ulrich Alexander Reinisch-Liese
Background and objective of the study: Hospitals, especially surgical departments, are among the largest producers of waste in Germany. Data on waste management in the operating room (OR) are largely lacking. The aim of t...
Margaretha A Skowron,Lisa Schneider,Evangelos Prokakis et al. Margaretha A Skowron et al.
Type II testicular germ cell tumors (GCT) are the most common malignant disease in young men, with a steadily increasing incidence. They originate from germ cell neoplasia in situ and are classified into seminomas (SE) and nonseminomas (NS)...
Johannes Hermann Kilz,Karl-Friedrich Kowalewski Johannes Hermann Kilz
As part of the improvement of perioperative standards the preoperative period before major urosurgical procedures is becoming increasingly more important. The concept of prehabilitation aims to raise the physical and mental capacities of pa...
Yue Che,Alexandros Papachristofilou Yue Che
Background: Stage IIA/B seminoma is cured in over 90% of cases with standard therapies (polychemotherapy, large-volume radiotherapy). However, these treatments are associated with potential late toxicities. ...